Pain and Comfort Levels During Heel Stick Blood Sampling in Newborns
ConditionNewborn
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-1
SponsorTarsus University
About this trial
Aim: The study was designed to determine the effect of Buzzy® and Shotbloker® application on pain and comfort levels in newborns during heel pricking. Method:The study was a randomised controlled trial. The study sample consisted of 159 newborns (Buzzy: 53, Shotbloker: 53, control: 53) who had heel pricks between March 2025 and December 2025 at the Samandağ State Hospital Neonatal Care Unit. The data collection tools used will be the Newborn Information Form, the Newborn Pain Scale, the Newborn Comfort Behaviour Scale, and the Buzzy® and Shotbloker® devices. In the intervention group, the Buzzy® and Shotbloker® devices will be applied before and after heel pricking, while the control group will receive routine care. The infants' pain and comfort levels will be assessed by the nurse before and after the procedure.
Eligibility criteria
Qualifiers
The baby must be full-term (38-42 weeks),
No analgesic administration up to 8 hours prior to the procedure,
No pain prior to the procedure,
No chronic or metabolic disease,
Disqualifiers
The baby is not full-term,
Analgesic medication has been administered within 8 hours prior to the procedure,
The baby has a chronic or metabolic disease,
The baby requires oxygen support,
Trial design
Treatments tested in this trial
- Buzzy®.Group
- ShotBlocker Group
Treatment groups
159 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov